Author： Miller Paul D
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.12, 2003-12, pp. : 2253-2258
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Safety concerns with the long-term management of osteoporosis
Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. :
Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis
Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. :
Long-Term Safety of Bisphosphonate Therapy for Osteoporosis: A Review of the Evidence
Drugs & Aging, Vol. 23, Iss. 4, 2006-01 ,pp. :
Safety Considerations with Bisphosphonates for the Treatment of Osteoporosis
Drug Safety, Vol. 30, Iss. 9, 2007-01 ,pp. :